![]() |
市場調査レポート
商品コード
1718951
日本の分析標準市場:製品別、技法別、用途別、地域別、機会、予測、2018年~2032年Japan Analytical Standards Market Assessment, By Product, By Technique, By Application, By Region, Opportunities and Forecast, FY2018-FY2032F |
||||||
カスタマイズ可能
|
日本の分析標準市場:製品別、技法別、用途別、地域別、機会、予測、2018年~2032年 |
出版日: 2025年05月05日
発行: Market Xcel - Markets and Data
ページ情報: 英文 105 Pages
納期: 3~5営業日
|
日本の分析標準の市場規模は、2025年から2032年にかけて6.50%のCAGRで拡大し、2024年の7,233万米ドルから2032年には1億1,970万米ドルになると予測されています。日本の分析標準市場は、医薬品と食品安全における厳しい規制環境とバイオテクノロジーの技術革新の影響を受けており、政府の「創薬ランド」戦略は医薬品開発のための高度な分析技術に焦点を当てています。バイオ医薬品の生産と臨床試験施設の増加は、品質管理と規制目的のために一貫した標準を必要とする一方、日本の食品衛生法に基づく厳しい衛生検査と添加物検査は、食品安全における有効な手順の需要を高めています。クロマトグラフィと分光学技術の進歩は測定精度を向上させ、産業界での採用をさらに後押ししています。工業化の進展と国民の公害に対する懸念が環境モニタリングの必要性を生み出し、先進的な分析技術を開発するための政府後援の研究開発努力と研究機関の提携によって補完されています。高齢化社会の医療ニーズと世界のバイオ医薬品の競合が交差していることも、日本が最先端の分析標準を重視する要因となっています。
日本政府は食品安全に関して厳しい規制を課しており、これが分析標準試料への需要をさらに高めています。さらに、研究機関や市場関係者は、食品安全基準を維持するために高度な分析技術を使用する努力を重ねています。日本の分析標準器市場は、経済の拡大と技術の進歩により大きく成長しています。好調な経済が研究開発への高額の投資を促進し、その結果、高度な分析機器や分析技術が発明されます。特にクロマトグラフィや分光法などの分析機器における技術の進歩は、分析標準物質の精度と信頼性を高めています。その結果、医薬品、食品安全、環境モニタリングの分野で分析用標準物質の需要が増加しています。そのため、技術革新と品質に対する日本のコミットメントが、高い製品試験と品質管理基準を保証しています。
日本における革新的な医薬品開発と、製薬部門への多額の政府投資は、日本の分析標準器市場を大いに強化しています。このような最先端のヘルスケアへのコミットメントは、医薬品製剤の正確な分析方法を必要とするため、この国では、卓越した医薬品へのコミットメントを反映して、高度な分析標準試料への需要が増加しています。例えば、日本政府は2024年7月、世界のバイオ医薬品市場における地位を強化するため、2028年までの「創薬立国」ロードマップを発表しました。この計画では、臨床試験施設の増加、ベンチャーキャピタルの拡大、世界的製薬会社の投資、さらに創薬ベンチャー企業への非公開会社の資金提供や投資に重点が置かれています。さらに、日本政府は2022年に経済産業省と共同で、2027年までに新興企業への投資を10倍に増やす「新興経済諸国開発5ヵ年計画」を導入しました。このイニシアチブを通じ、経済産業省は2024年1月、官民の協力と投資を奨励するため、シリコンバレーにジャパン・イノベーション・キャンパスを開設しました。このように、バイオ医薬品分野での新興企業の増加は、様々な分析システムの需要をさらに増加させ、国内の市場成長を支えると思われます。
当レポートでは、日本の分析標準市場について調査し、市場の概要とともに、製品別、技法別、用途別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Japan analytical standards market is predicted to grow at a CAGR of 6.50% between FY2025 and FY2032, rising from USD 72.33 million in FY2024 to USD 119.70 million by FY2032. Japan analytical standard market is influenced by stringent regulatory environments in pharmaceuticals and food safety, combined with biotechnology innovation, with the government's "drug discovery land" strategy focusing on advanced analytical technologies for drug development. Increased biopharmaceutical production and clinical trial facilities require consistent standards for quality control and regulatory purposes, while severe hygiene and additive testing under Japan's Food Sanitation Law heighten demand for validated procedures in food safety. Advancements in chromatography and spectroscopy technologies improve measurement accuracy, further boosting adoption in industries. Increased industrialization and concern about pollution among the populace generate environmental monitoring requirements, supplemented by government-sponsored R&D efforts and research institution partnerships to develop advanced analytical techniques. The intersection of an aging population's health care needs and global biopharma competitiveness additionally locks into Japan's emphasis on state-of-the-art analytical standards.
Government of Japan has imposed strict regulations regarding food safety, which has further increased the demand for analytical standards. Additionally, research institutes and market players combined their efforts to use advanced analytical techniques to maintain food safety standards. The analytical standards market in Japan is growing highly due to economic expansion and technology advancement. Its strong economy promotes high investments in research and development, which results in the invention of advanced analytical instruments and techniques. Technological advancements, especially in analytical instruments such as chromatography and spectroscopy, increase the accuracy and reliability of analytical standards. This has resulted in increased demand for analytical standards in pharmaceuticals, food safety, and environmental monitoring. Therefore, Japan's commitment to innovation and quality ensures high product testing and quality control standards.
Innovative drug development in Japan and considerable government investments in the pharmaceutical sector are greatly enhancing the country's analytical standards market. This commitment to state-of-the-art healthcare requires accurate analytical methods for drug formulations, and therefore, the demand for advanced analytical standards is increasing in this nation, reflecting its commitment to pharmaceutical excellence. For instance, in July 2024, Japanese government has launched a 'drug discovery land' roadmap until 2028, to strengthen their position in the global biopharmaceutical market. The plan focuses on increase of clinical trial facilities, expansion of venture capital and investments of global pharmaceutical companies, as well as private funding & investment in drug discovery start-ups. Moreover, in FY 2022, Japanese government in collaboration with The Ministry of Economy, Trade and Industry (METI) has introduced 'the Startup Development Five-Year Plan' to increase startup investment tenfold by 2027. Through this initiative, in January 2024, METI has launched Japan Innovation Campus in Silicon Valley to encourage private-public collaborations and investments. Thus, rising number of start-ups in the biopharma field will further increase the demand for various analytical systems; supporting the market growth in the country.
Expanding Pharmaceuticals and Biotechnology Industries Impacting Japan Analytical Standards Market
The growth of pharmaceutical and biotech companies in Japan and the increase in their manufacturing facilities is significantly boosting the country's analytical standards market. With these companies increasing production to meet global demands, accurate and reliable analytical methods are needed. Advanced analytical standards are required to maintain quality control and regulatory compliance, creating demand for high-precision testing tools and methodologies. This expansion reflects the broader growth and innovation within Japan's pharmaceutical sector, reinforcing the importance of stringent analytical standards to support developing and manufacturing high-quality pharmaceuticals and biotechnology products. As a result, the analytical standards market is booming with the dynamic growth of Japan's pharmaceutical and biotech industries.
For instance, in January 2024, AGC Biologics S.p.A., expanding from its Chiba site, established a new Yokohama facility to expand preclinical and commercial production of protein biologics, cell therapies, and mRNA therapies. This expansion caters to the high regional demand for quality biopharmaceutical partners, thus raising the need for advanced analytical standards in Japan.
Rising Concern for Food Safety
The growing awareness of food safety in Japan bolsters the growth of the analytical standards market. As public awareness increases and the regulatory framework becomes more stringent, there is a need for accurate testing techniques to identify contaminants and ensure the quality of food. Hence, the demand for sophisticated analytical standards has increased, which supports the advancement of techniques like chromatography and mass spectrometry. These techniques are critical to maintaining high food safety standards and meeting regulatory compliance. This trend is underpinned by the need for good analytical standards to protect public health and ensure food safety, thereby significantly boosting the analytical standards market in Japan. On every 7th June, World Food Safety Day highlights the significance of safe food for health and prosperity. The Japan International Research Center for Agricultural Sciences (JIRCAS) actively advocates food safety awareness through campaigns such as education programs and collaborations with international organizations. Japan recently implemented the "Strategy MIDORI" on sustainable food systems, again emphasizing food safety. Public awareness in Japan is on the rise, and better analytical standards are needed to ensure the quality and safety of food.
Stringent Regulations for Environmental Monitoring Propels Market Growth
Environmental protection is increasingly becoming Japan's number one concern, with stricter regulations against air, water, and ground pollution. The government has reinforced laws like the Air Pollution Control Act and Water Pollution Control Law, which require testing for contaminants like heavy metals, PFAS, and VOCs. Tokyo authorities in 2022 amended soil contamination regulations, which resulted in more intensive and frequent testing. These tests involve certified reference materials to verify accuracy. As labs and industries try to meet new environmental standards, they require a greater range of analytical standards. This rule is driving demand directly in the environmental testing market. Increased emphasis on sustainability is also causing firms to practice more open testing methods. This establishes a steady need for reference materials tailored for the environment.
The Pharmaceutical & Life Sciences Segment holds a Major Market Share of the Analytical Standards Market
The pharmaceutical and life sciences segment has the highest market share in Japanese analytical standards. This is primarily because of the very stringent requirement for accuracy and reliability. This sector also increases with the need for high-quality testing for maintaining strict regulatory compliance. Advanced analytical standards are significant in verifying new drug formulations, as well as product consistency. International standards need to be maintained as well. Moreover, the emphasis on new drug development and biotechnology increases the need for advanced analytical techniques. With an increase in manufacturing facilities and new therapies, the importance of strong analytical testing is also increasing. Thus, the above dependency of this segment to deliver its results based on correct analytical standards only increases its market leadership.
For instance, in September 2024, Shimadzu Corporation invested in Sepragen Corporation, known for its purification chromatography equipment. This investment enabled Shimadzu to sell and service Sepragen's products exclusively in Japan, Korea, and Southeast Asia, thereby enhancing the biopharmaceutical manufacturing process. This step highlights the substantial share of the Pharmaceutical & Life Sciences segment in Japan's analytical standards market because of the demand for advanced purification and testing methods.
Future Market Scenario (FY2025-FY2032F)
Several factors are expected to drive the analytical standards market in Japan in the future. Public awareness about safety of food, stringent regulatory expectations, and advancements in pharmaceutical as well as biotechnology are the major drivers. They require accurate testing techniques and standard quality for compliance and overall product quality. Government policies stimulating innovation and higher R&D investments further drive market, displaying Japan's interest in staying ahead with high standards.
For instance, in July 2024, Japan Association for Cellular Agriculture (JACA), a non-profit think tank, published an in-depth report in the global safety assessment and regulatory trends on cultured food. This report offers valuable insights to the cultivated food industry in Japan, emphasizing critical safety considerations. JACA aims to build consensus on necessary measures for cellular agriculture companies regulated in Japan. This increasing demand on food safety is likely to drive the growth of the analytical standards market for the years ahead in Japan.
Key Players Landscape and Outlook
Major players in Japan's analytical standards market are highly investing in new product development to enhance the quality of new drugs and biotechnological products. Their approach includes new product introduction and facilities expansion as they expand their manufacturing volume, which leads to further growth in the market with high standards for pharmaceutical and biotechnology industries.
In November 2024, Agilent Technologies Inc., the Japanese subsidiary of the US-based Agilent Technologies, launched a new liquid chromatograph. The new product automates several analytical tasks, thus helping reduce the workload of researchers. The product is designed for use in pharmaceutical and food industries, academia, and CDMOs. By boosting the efficiency of operations, this launch further consolidates Agilent's market leadership and demonstrates its commitment to cutting-edge technological solutions.
In December 2024, Merck invested approximately USD 80 million in its Advanced Materials Development Centre (AMDC) at Shizuoka, Japan. With this investment, the company's total investment at the site, which also houses the Patterning Centre of Excellence, totals USD 136 million since 2021. The site will focus on developing and manufacturing analytical standards, advanced materials and technologies and feature a 5,500 meter square facility with advanced laboratories and cleanrooms.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.